Correlation Between Pfizer and Blackstone Alternative

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Blackstone Alternative at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Blackstone Alternative into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Blackstone Alternative Multi Strategy, you can compare the effects of market volatilities on Pfizer and Blackstone Alternative and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Blackstone Alternative. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Blackstone Alternative.

Diversification Opportunities for Pfizer and Blackstone Alternative

-0.8
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Pfizer and Blackstone is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Blackstone Alternative Multi S in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blackstone Alternative and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Blackstone Alternative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blackstone Alternative has no effect on the direction of Pfizer i.e., Pfizer and Blackstone Alternative go up and down completely randomly.

Pair Corralation between Pfizer and Blackstone Alternative

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Blackstone Alternative. In addition to that, Pfizer is 7.33 times more volatile than Blackstone Alternative Multi Strategy. It trades about -0.16 of its total potential returns per unit of risk. Blackstone Alternative Multi Strategy is currently generating about 0.19 per unit of volatility. If you would invest  1,107  in Blackstone Alternative Multi Strategy on September 16, 2024 and sell it today you would earn a total of  26.00  from holding Blackstone Alternative Multi Strategy or generate 2.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  Blackstone Alternative Multi S

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Blackstone Alternative 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Blackstone Alternative Multi Strategy are ranked lower than 15 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong forward indicators, Blackstone Alternative is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pfizer and Blackstone Alternative Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Blackstone Alternative

The main advantage of trading using opposite Pfizer and Blackstone Alternative positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Blackstone Alternative can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blackstone Alternative will offset losses from the drop in Blackstone Alternative's long position.
The idea behind Pfizer Inc and Blackstone Alternative Multi Strategy pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets